
Sentinel lymph node biopsy underused in high-risk SCC
(HealthDay)—Sentinel lymph node biopsy (SLNB) is underused for high-risk squamous cell carcinoma (SCC) of the skin, according to a research letter published online Nov. 15 in JAMA Dermatology.
Nov 16, 2017
0
0